Analysts have been under intense pressure in recent months as they try to make sense of the impact of Covid-19 on companies like Abcam (LON:ABC). As one of just 200 shares in the UK market valued at more than £1.0 billion (its market c...
ABC — Abcam Share Price
0.000.00%
Last Trade - 00:00HealthcareBalancedLarge CapFalling Star
- £3.40bn
- £3.31bn
- £269.30m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 62.09 | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 171.67 | 217.1 | 233.2 | 259.9 | 260 | 346.49 | 349 | 12.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.03 | +7.37 | +84.8 | -15.35 | -31.45 | -18.02 | +24.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for ABC
It has been a wild ride for some of the UK's biggest quoted companies this year. Economic uncertainty persists and the question on the minds of many investors is where the prices of stocks like Abcam (LON:ABC) will go from here. Abcam...
Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect large cap shares, such as the share price of Abcam (LO...
Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - and Abcam (LON:ABC) could be one of them. To understand why different shares resp...
Shares in Abcam (LON:ABC) have outperformed the market over the past three months, signalling optimism on the part of investors at a time of economic uncertainty. Based on relative price strength against the market, the company's share...
Profile Summary
Abcam plc is a global life sciences company. The Company identifies, develops, and provides biological reagents and tools, which are required in a range of fields and applications including drug discovery, diagnostics and basic research. The Company’s solutions include research use only (RUO) proteomic tools and antibody development for clinical application. The RUO proteomic products include protein binding reagents, such as antibodies and immunoassays, and related reagents. The Company’s products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The Company serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.
Directors
- Alan Hirzel CEO
- Michael Baldock (56)
- Marc Perkins
- Mark Capone (58)
- Chienling Lee (55)
- Mara Aspinall NID (58)
- Giles Kerr NID (60)
- Last Annual
- June 30th, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- February 12th, 1998
- Public Since
- November 3rd, 2005
- No. of Employees
- 1,500
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 226,765,655
- Address
- Discovery Drive, CAMBRIDGE, CB20AX
- Web
- http://www.abcam.com/
- Phone
- +44 1223696000
- Contact
- James Staveley
- Auditors
- PricewaterhouseCoopers LLP
Latest News for ABC
Upcoming events for ABC
Similar to ABC
AMRYT PHARMA ORD
London Stock Exchange
OKYO PHARMA ORD
London Stock Exchange
FAQ
What is the Abcam share price?
As of Today at 19:54 UTC, shares in Abcam are trading at 1,500.00p. This share price information is delayed by 15 minutes.
How has the Abcam share price performed this year?
Shares in Abcam last closed at 1,500.00p and the price had moved by +12.11% over the past 365 days. In terms of relative price strength the Abcam share price has underperformed the FTSE All Share Index by -8.38% over the past year.
What are the analyst and broker recommendations for Abcam?
The overall consensus recommendation for Abcam is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Abcam dividend yield?
Abcam does not currently pay a dividend.
Does Abcam pay a dividend?
Abcam does not currently pay a dividend.
When does Abcam next pay dividends?
Abcam does not currently pay a dividend.
How do I buy Abcam shares?
To buy shares in Abcam you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Abcam?
As of the previous close price of 1,500.00p, shares in Abcam had a market capitalisation of £3.40bn.
Where are Abcam shares listed?
Here are the trading details for Abcam:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: ABC
What kind of share is Abcam?
Based on an overall assessment of its quality, value and momentum Abcam is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Abcam share price forecast for 2021?
The analyst consensus target price for shares in Abcam is 1,401.63p. That is 6.56% below the last closing price of 1,500.00p.
Analysts covering Abcam currently have a consensus Earnings Per Share (EPS) forecast of £0.19 for the next financial year.
What is the trend in the Abcam share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abcam. Over the past six months, its share price has underperformed the FTSE All Share Index by -20.49%.
As of the last closing price of 1,500.00p, shares in Abcam were trading +1.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Abcam PE Ratio?
The Abcam PE ratio based on its reported earnings over the past 12 months is 77.16. The shares last closed at 1,500.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Abcam?
Abcam's management team is headed by:
- Alan Hirzel - CEO
- Michael Baldock -
- Marc Perkins -
- Mark Capone -
- Chienling Lee -
- Mara Aspinall - NID
- Giles Kerr - NID
Who are the major shareholders of Abcam?
We do not have data on Abcam's shareholders